Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies

Human Immunology

Volumn 66, Issue 5, 2005, Pages 501-512

  Colovai, Adriana I ^a   Vasilescu, Elena R ^a   Foca Rodi, Aurica ^a   Kim Schulze, Seunghee ^a   Hussaini, Najeeb ^a   D'Agati, Vivette D ^a   Markowitz, Glen S ^a   Wang, Chuan ^a   Cohen, David J ^a   Hardy, Mark A ^a   Suciu Foca, Nicole ^a  

^a Columbia University ^*  (United States)

Author keywords

Antibody mediated rejection; Atgam; Endothelial cells; Renal transplantation; Thymoglobulin

Indexed keywords

THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW MEASUREMENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MALE; NEPHRECTOMY; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTILYMPHOCYTE SERUM; ENDOTHELIAL CELLS; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HORSES; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; RABBITS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 20444416744     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.01.009     Document Type: Article

References (42)

1. W.C. Goggins, M.A. Pascual, J.A. Powelson, C. Magee, N. Tolkoff-Rubin, M.L. Farrell, D.S. Ko, W.W. Williams, A. Chandraker, F.L. Delmonico, H. Auchincloss, A.B. Cosimi A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients Transplantation 76 2003 798
2. D.C. Brennan, K. Flavin, J.A. Lowell, T.K. Howard, S. Shenoy, S. Burgess, S. Dolan, J.M. Kano, M. Mahon, M.A. Schnitzler, R. Woodward, W. Irish, G.G. Singer A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients Transplantation 67 1999 1011
3. M.R. Marvin, C. Droogan, D. Sawinski, D.J. Cohen, M.A. Hardy Administration of rabbit antithymocyte globulin (Thymoglobulin) in ambulatory renal-transplant patients Transplantation 75 2003 488
4. M. Buchler, B. Hurault de Ligny, C. Madec, Y. Lebranchu Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation a 1-yr follow-up of safety and efficacy Clin Transplant 17 2003 539
5. K.L. Hardinger, M.A. Schnitzler, B. Miller, J.A. Lowell, S. Shenoy, M.J. Koch, D. Enkvetchakul, C. Ceriotti, D.C. Brennan Five-year follow up of Thymoglobulin versus ATGAM induction in adult renal transplantation Transplantation 78 2004 136
6. J. Marsh, H. Schrezenmeier, P. Marin, O. Ilhan, P. Ljungman, S. McCann, G. Socie, A. Tichelli, J. Passweg, J. Hows, A. Raghavachar, A. Locasciulli, A. Bacigalupo Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party Blood 93 1999 2191
7. R. Storb, E. Gluckman, E.D. Thomas, C.D. Buckner, R.A. Clift, A. Fefer, H. Glucksberg, T.C. Graham, F.L. Johnson, K.G. Lerner, P.E. Neiman, H. Ochs Treatment of established human graft-versus-host disease by antithymocyte globulin Blood 44 1974 56
8. O. Ringden, M. Remberger, S. Carlens, H. Hagglund, J. Mattsson, J. Aschan, B. Lonnqvist, S. Klaesson, J. Winiarski, T. Dalianis, O. Olerup, E. Sparrelid, A. Elmhorn-Rosenborg, B.M. Svahn, P. Ljungman Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies Transplantation 66 1998 620
9. A.J. Fabrega, J. DeChristopher, S.D. Sosler, P.A. Rivas, E.M. Vasquez, R. Pollak Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation contributory role of HLA matching and polyclonal antilymphocyte globulin Clin Transplant 10 1996 166
10. D. Ducloux, A. Kazory, B. Challier, J. Coutet, C. Bresson-Vautrin, G. Motte, B. Thalamy, J.M. Rebibou, J.M. Chalopin Long-term toxicity of antithymocyte globulin induction may vary with choice of agent a single-center retrospective study Transplantation 77 2004 1029
11. L.M. Rebellato, U. Gross, K.M. Verbanac, J.M. Thomas A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin Transplantation 57 1994 685
12. M.C. Michallet, X. Preville, M. Flacher, S. Fournel, L. Genestier, J.P. Revillard Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 2003 657
13. J.S. Bourdage, D.M. Hamlin Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry Transplantation 59 1995 1194
14. B. Greco, L. Bielory, D. Stephany, S.M. Hsu, P. Gascon, A. Nienhuis, N. Young Antithymocyte globulin reacts with many normal human cell types Blood 62 1983 1047
15. N. Bonnefoy-Berard, J.P. Revillard Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3 J Heart Lung Transplant 15 1996 435
16. F. Vincenti, R. Kirkman, S. Light, G. Bumgardner, M. Pescovitz, P. Halloran, J. Neylan, A. Wilkinson, H. Ekberg, R. Gaston, L. Backman, J. Burdick Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group N Engl J Med 338 1998 161
17. S.J. Knechtle, J.D. Pirsch, J.J. Fechner, B.N. Becker, A. Friedl, R.B. Colvin, L.K. Lebeck, L.T. Chin, Y.T. Becker, J.S. Odorico, A.M. D'Alessandro, M. Kalayoglu, M.M. Hamawy, H. Hu, D.D. Bloom, H.W. Sollinger Campath-1H induction plus rapamycin monotherapy for renal transplantation results of a pilot study H. Am J Transplant 3 2003 722
18. T.F. Muller, S.O. Grebe, M.C. Neumann, J. Heymanns, K. Radsak, H. Sprenger, H. Lange Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies Transplantation 64 1997 1432
19. L. Genestier, S. Fournel, M. Flacher, O. Assossou, J.P. Revillard, N. Bonnefoy-Berard Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins Blood 91 1998 2360
20. X. Preville, M. Flacher, B. LeMauff, S. Beauchard, P. Davelu, J. Tiollier, J.P. Revillard Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model Transplantation 71 2001 460
21. J. Choi, D.R. Enis, K.P. Koh, S.L. Shiao, J.S. Pober T lymphocyte-endothelial cell interactions Annu Rev Immunol 22 2004 683
22. W.J. Wechter, J.W. Nelson, R.J. Perper, A.J. Parcells, K.W. Riebe, J.S. Evans, P.S. Satoh, H. Ko Manufacture of antithymocyte globulin (ATGAM) for clinical trials Transplantation 28 1979 303
23. X. Preville, L. Nicolas, M. Flacher, J. Revillard A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG) J Immunol Methods 245 2000 45
24. R.A. Bray Flow cytometry crossmatching for solid organ transplantation Methods Cell Biol 41 1994 103
25. J.S. Manavalan, S. Kim-Schulze, L. Scotto, A.J. Naiyer, G. Vlad, P.C. Colombo, C. Marboe, D. Mancini, R. Cortesini, N. Suciu-Foca Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity Int Immunol 16 2004 1055
26. L.C. Racusen, R.B. Colvin, K. Solez, M.J. Mihatsch, P.F. Halloran, P.M. Campbell, M.J. Cecka, J.P. Cosyns, A.J. Demetris, M.C. Fishbein, A. Fogo, P. Furness, I.W. Gibson, D. Glotz, P. Hayry, L. Hunsickern, M. Kashgarian, R. Kerman, A.J. Magil, R. Montgomery, K. Morozumi, V. Nickeleit, P. Randhawa, H. Regele, D. Seron, S. Seshan, S. Sund, K. Trpkov Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection Am J Transplant 3 2003 708
27. E.K. Waller, A.A. Langston, S. Lonial, J. Cherry, J. Somani, A.J. Allen, H. Rosenthal, I. Redei Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biol Blood Marrow Transplant 9 2003 460
28. A. Valujskikh, P.S. Heeger Emerging roles of endothelial cells in transplant rejection Curr Opin Immunol 15 2003 493
29. D.J. Pidwell, M.J. Heller, D. Gabler, C.G. Orosz In vitro stimulation of human endothelial cells by sera from a subpopulation of high-percentage panel-reactive antibody patients Transplantation 60 1995 563
30. S.K. Takemoto, A. Zeevi, S. Feng, R.B. Colvin, S. Jordan, J. Kobashigawa, J. Kupiec-Weglinski, A. Matas, R.A. Montgomery, P. Nickerson, J.L. Platt, H. Rabb, R. Thistlethwaite, D. Tyan, F.L. Delmonico National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033
31. D.S. Warren, A.A. Zachary, C.J. Sonnenday, K.E. King, M. Cooper, L.E. Ratner, R.S. Shirey, M. Haas, M.S. Leffell, R.A. Montgomery Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers Am J Transplant 4 2004 561
32. G.A. Bohmig, M. Exner, A. Habicht, M. Schillinger, U. Lang, J. Kletzmayr, M.D. Saemann, W.H. Horl, B. Watschinger, H. Regele Capillary C4d deposition in kidney allografts a specific marker of alloantibody-dependent graft injury J Am Soc Nephrol 13 2002 1091
33. R. Pei, J. Lee, T. Chen, S. Rojo, P.I. Terasaki Flow cytometric detection of HLA antibodies using a spectrum of microbeads Hum Immunol 60 1999 1293
34. E.R. Vasilescu, E.K. Ho, L. de la Torre, S. Itescu, C. Marboe, R. Cortesini, N. Suciu-Foca, D. Mancini Anti-HLA antibodies in heart transplantation Transpl Immunol 12 2004 177
35. P.C. Lee, P.I. Terasaki, S.K. Takemoto, P.H. Lee, C.J. Hung, Y.L. Chen, A. Tsai, H.Y. Lei All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies Transplantation 74 2002 1192
36. E.F. Reed Signal transduction via MHC class I molecules in endothelial and smooth muscle cells Crit Rev Immunol 23 2003 109
37. M. Crespo, M. Pascual, N. Tolkoff-Rubin, S. Mauiyyedi, A.B. Collins, D. Fitzpatrick, M.L. Farrell, W.W. Williams, F.L. Delmonico, A.B. Cosimi, R.B. Colvin, S.L. Saidman Acute humoral rejection in renal allograft recipients I. Incidence, serology and clinical characteristics Transplantation 71 2001 652
38. M. Takada, K.C. Nadeau, G.D. Shaw, K.A. Marquette, N.L. Tilney The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand J Clin Invest 99 1997 2682
39. R.S. Al-Lamki, J. Wang, J.N. Skepper, S. Thiru, J.S. Pober, J.R. Bradley Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants Lab Invest 81 2001 1503
40. K.A. Muczynski, D.M. Ekle, D.M. Coder, S.K. Anderson Normal human kidney HLA-DR-expressing renal microvascular endothelial cells characterization, isolation, and regulation of MHC class II expression J Am Soc Nephrol 14 2003 1336
41. G.J. Jaffers, T.C. Fuller, A.B. Cosimi, P.S. Russell, H.J. Winn, R.B. Colvin Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression Transplantation 41 1986 572
42. H. Ma, E.H. Hammond, D.O. Taylor, R.L. Yowell, M.R. Bristow, J.B. O'Connell, D.G. Renlund The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3) Transplantation 62 1996 205